DK2000465T3 - Triazolonderivat - Google Patents
TriazolonderivatInfo
- Publication number
- DK2000465T3 DK2000465T3 DK07739256.1T DK07739256T DK2000465T3 DK 2000465 T3 DK2000465 T3 DK 2000465T3 DK 07739256 T DK07739256 T DK 07739256T DK 2000465 T3 DK2000465 T3 DK 2000465T3
- Authority
- DK
- Denmark
- Prior art keywords
- optionally substituted
- independently represent
- represent hydrogen
- represents optionally
- triazolone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006083486 | 2006-03-24 | ||
US78668706P | 2006-03-29 | 2006-03-29 | |
JP2006162594 | 2006-06-12 | ||
US80487806P | 2006-06-15 | 2006-06-15 | |
JP2006218819 | 2006-08-10 | ||
US83841806P | 2006-08-18 | 2006-08-18 | |
PCT/JP2007/055813 WO2007111212A1 (ja) | 2006-03-24 | 2007-03-22 | トリアゾロン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2000465T3 true DK2000465T3 (da) | 2011-02-07 |
Family
ID=38950011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07739256.1T DK2000465T3 (da) | 2006-03-24 | 2007-03-22 | Triazolonderivat |
Country Status (26)
Country | Link |
---|---|
US (3) | US7816522B2 (da) |
EP (2) | EP2000465B1 (da) |
JP (1) | JP5016592B2 (da) |
KR (1) | KR101362024B1 (da) |
AT (2) | ATE491694T1 (da) |
AU (1) | AU2007230346B2 (da) |
BR (1) | BRPI0709101A2 (da) |
CA (1) | CA2647423C (da) |
CY (1) | CY1111271T1 (da) |
DE (1) | DE602007011231D1 (da) |
DK (1) | DK2000465T3 (da) |
HK (1) | HK1123808A1 (da) |
HR (1) | HRP20110054T1 (da) |
IL (1) | IL194188A (da) |
MX (1) | MX2008012031A (da) |
MY (1) | MY146537A (da) |
NO (1) | NO20084441L (da) |
NZ (1) | NZ571441A (da) |
PL (1) | PL2000465T3 (da) |
PT (1) | PT2000465E (da) |
RS (1) | RS52030B (da) |
SA (1) | SA07280131B1 (da) |
SI (1) | SI2000465T1 (da) |
TW (1) | TWI389894B (da) |
WO (1) | WO2007111212A1 (da) |
ZA (1) | ZA200805758B (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4478157B2 (ja) * | 2004-10-13 | 2010-06-09 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヒドラジド誘導体 |
BRPI0709101A2 (pt) * | 2006-03-24 | 2011-06-28 | Eisai R&D Man Co Ltd | derivados de triazolona e medicamento e agente terapêutico e/ou profilático compreendendo os mesmos |
US7807690B2 (en) | 2007-09-21 | 2010-10-05 | Eisai R&D Management Co., Ltd. | 2,3-dihydro-iminoisoindole derivatives |
BRPI0818679A2 (pt) * | 2007-10-26 | 2015-04-14 | Astrazeneca Ab | Composto, composição farmacêutica, uso de um composto, métodos para a inibição dos relaxamentos do sefíncter esofágico inferior transitórios, para o tratamento ou a prenveção da doença do refluxo gastroesfágico, de dor, da ansiedade, e da sídrome do intestino irritável, e, combinação |
TW200924774A (en) * | 2007-10-26 | 2009-06-16 | Astrazeneca Ab | Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mGluR5 |
TW201206905A (en) * | 2010-05-20 | 2012-02-16 | Eisai R & Amp D Man Co Ltd | Prodrug of triazolone compound |
WO2013134562A1 (en) * | 2012-03-09 | 2013-09-12 | Inception 2, Inc. | Triazolone compounds and uses thereof |
CN102993109A (zh) * | 2012-12-03 | 2013-03-27 | 浙江工业大学 | 一种脒化合物的制备方法 |
KR102300675B1 (ko) | 2012-12-20 | 2021-09-13 | 템페스트 테라퓨틱스, 인코포레이티드 | 트리아졸론 화합물 및 이의 용도 |
MX2016002795A (es) | 2013-09-06 | 2016-05-26 | Inception 2 Inc | Compuestos de triazolona y usos de los mismos. |
CN110291383B (zh) * | 2017-02-23 | 2021-12-28 | 株式会社Ihi | Oh自由基检测探测器、oh自由基测定装置以及oh自由基测定方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2005000A (en) * | 1931-07-18 | 1935-06-18 | L N Miller Engineering Corp | Differential motor |
EP0019586A1 (de) | 1979-05-11 | 1980-11-26 | Ciba-Geigy Ag | Neue antithrombotische Kombinationspräparate |
SU1512055A1 (ru) | 1987-12-04 | 1992-07-23 | Пермский фармацевтический институт | Дигидрохлорид гидразида N-ацетил-N-аллилантраниловой кислоты, про вл ющий антиагрегатную активность по отношению к тромбоцитам плазмы крови |
IL134394A0 (en) | 1997-08-27 | 2001-04-30 | Kissei Pharmaceutical | 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both |
AU2300699A (en) * | 1998-02-17 | 1999-08-30 | Ono Pharmaceutical Co. Ltd. | Amidino derivatives and drugs containing the same as the active ingredient |
AU3110999A (en) | 1998-03-27 | 1999-10-18 | Du Pont Pharmaceuticals Company | Disubstituted pyrazolines and triazolines as factor xa inhibitors |
NZ511927A (en) | 1998-12-14 | 2004-02-27 | F | Phenylglycine derivatives |
ATE307111T1 (de) * | 1999-01-13 | 2005-11-15 | Genentech Inc | Serinprotease-inhibitoren |
FR2791683A1 (fr) | 1999-03-30 | 2000-10-06 | Synthelabo | Derives de n-sulfonyl-dipeptides, leur preparation et leur application en therapeutique |
FR2793247B1 (fr) | 1999-05-04 | 2001-06-22 | Synthelabo | Derives de 6-[[(aryl et heteroaryl)oxy]methyl]naphtalene-2- carboximidamide, leur preparation et leur application en therapeutique |
US6548694B2 (en) * | 2000-05-23 | 2003-04-15 | Hoffman-La Roche Inc. | N-(4-carbamimidoyl-phenyl)-glycine derivatives |
EP1162194A1 (en) | 2000-06-06 | 2001-12-12 | Aventis Pharma Deutschland GmbH | Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
WO2002088092A1 (fr) * | 2001-04-19 | 2002-11-07 | Eisai Co., Ltd. | Derive de 2-imino-imidazole (2) |
JP4209659B2 (ja) * | 2001-11-15 | 2009-01-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | アミジノ誘導体並びにそれを用いた抗血液凝固剤および血栓症治療剤 |
EP1312602A1 (en) | 2001-11-15 | 2003-05-21 | Eisai Co., Ltd. | Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them |
EP1558581A4 (en) * | 2002-10-07 | 2007-07-25 | Bristol Myers Squibb Co | DERIVATIVES OF TRIAZOLONE AND TRIAZOLETHIONE |
EP1479679A1 (en) | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Triazole-derivatives as factor Xa inhibitors |
JP4478157B2 (ja) | 2004-10-13 | 2010-06-09 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヒドラジド誘導体 |
AR051984A1 (es) * | 2004-12-08 | 2007-02-21 | Bristol Myers Squibb Co | Compuestos heterociclicos como inhibidores del factor viia |
BRPI0709101A2 (pt) | 2006-03-24 | 2011-06-28 | Eisai R&D Man Co Ltd | derivados de triazolona e medicamento e agente terapêutico e/ou profilático compreendendo os mesmos |
US7807690B2 (en) * | 2007-09-21 | 2010-10-05 | Eisai R&D Management Co., Ltd. | 2,3-dihydro-iminoisoindole derivatives |
-
2007
- 2007-03-22 BR BRPI0709101-0A patent/BRPI0709101A2/pt not_active IP Right Cessation
- 2007-03-22 MX MX2008012031A patent/MX2008012031A/es active IP Right Grant
- 2007-03-22 DE DE602007011231T patent/DE602007011231D1/de active Active
- 2007-03-22 PT PT07739256T patent/PT2000465E/pt unknown
- 2007-03-22 WO PCT/JP2007/055813 patent/WO2007111212A1/ja active Application Filing
- 2007-03-22 SI SI200730515T patent/SI2000465T1/sl unknown
- 2007-03-22 PL PL07739256T patent/PL2000465T3/pl unknown
- 2007-03-22 AT AT07739256T patent/ATE491694T1/de active
- 2007-03-22 RS RS20110118A patent/RS52030B/en unknown
- 2007-03-22 AT AT10157326T patent/ATE557010T1/de active
- 2007-03-22 DK DK07739256.1T patent/DK2000465T3/da active
- 2007-03-22 CA CA2647423A patent/CA2647423C/en not_active Expired - Fee Related
- 2007-03-22 KR KR1020087025698A patent/KR101362024B1/ko not_active IP Right Cessation
- 2007-03-22 EP EP07739256A patent/EP2000465B1/en active Active
- 2007-03-22 MY MYPI20083555A patent/MY146537A/en unknown
- 2007-03-22 EP EP10157326A patent/EP2194046B1/en active Active
- 2007-03-22 AU AU2007230346A patent/AU2007230346B2/en not_active Ceased
- 2007-03-22 US US11/723,893 patent/US7816522B2/en not_active Expired - Fee Related
- 2007-03-22 NZ NZ571441A patent/NZ571441A/en not_active IP Right Cessation
- 2007-03-22 JP JP2008507453A patent/JP5016592B2/ja not_active Expired - Fee Related
- 2007-03-23 TW TW096110040A patent/TWI389894B/zh not_active IP Right Cessation
- 2007-03-24 SA SA7280131A patent/SA07280131B1/ar unknown
-
2008
- 2008-07-01 ZA ZA2008/05758A patent/ZA200805758B/en unknown
- 2008-09-17 IL IL194188A patent/IL194188A/en not_active IP Right Cessation
- 2008-10-22 NO NO20084441A patent/NO20084441L/no not_active Application Discontinuation
-
2009
- 2009-04-21 HK HK09103660.4A patent/HK1123808A1/xx not_active IP Right Cessation
-
2010
- 2010-03-29 US US12/748,806 patent/US7928228B2/en not_active Expired - Fee Related
-
2011
- 2011-01-13 US US13/006,004 patent/US8163787B2/en not_active Expired - Fee Related
- 2011-01-24 HR HR20110054T patent/HRP20110054T1/hr unknown
- 2011-02-28 CY CY20111100231T patent/CY1111271T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2000465T3 (da) | Triazolonderivat | |
DK1277736T3 (da) | Hidtil ukendte bicykliske forbindelser | |
ATE544744T1 (de) | Verfahren zur herstellung von benzoesaure derivaten | |
DE60315265D1 (de) | Stickstoffhaltige heterocyclische verbindung und arzneimittel davon | |
ATE556058T1 (de) | 1-(2h)-isochinolonderivat | |
DE60002558D1 (de) | Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B | |
AR037698A1 (es) | N-[4-(1h-imidazol-1-il)-2-fluorofenil]-3-(trifluorometil)-1h-pirazol-5-carboxamidas como inhibidores del factor xa | |
WO2009038157A1 (ja) | 2,3-ジヒドロ-イミノイソインドール誘導体 | |
DK1899331T3 (da) | Homomorpholinoxazolidnoner som antibakterielle midler | |
ATE297902T1 (de) | Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren | |
EA200700322A1 (ru) | Оксазолидиноны, содержащие оксиндолы, в качестве антибактериальных агентов | |
NO20053997L (no) | Oligosaccharidderivat | |
HK1130496A1 (en) | 3'-ethynylcytidine derivative 3'- | |
DK1186607T3 (da) | Optisk aktive pyrrolopyridazinforbindelser | |
IL187917A (en) | Compounds 1– (Converted phenyl) -pyreno [3,4– b] [1] benzofuran-3-van | |
ATE361925T1 (de) | Pyrrolopyridazin-verbindungen | |
MA31206B1 (fr) | Dérivés cyclohexyl amide d'acide carboxylique aryle | |
ATE522499T1 (de) | Verfahren zur herstellung von tamsulosin und seinen derivaten | |
ATE279417T1 (de) | Neue carbapenem-derivate | |
TH96118A (th) | กรรมวิธีทางเคมี |